Your browser doesn't support javascript.
loading
A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease.
Simuni, Tanya; Merchant, Kalpana.
Affiliation
  • Simuni T; Department of Neurology Northwestern University Feinberg School of Medicine, 710 North Lake Shore Drive, 1126, Chicago, IL, 60611, USA. Electronic address: tatyana.simuni@nm.org.
  • Merchant K; Department of Neurology Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, 303 E. Chicago Ave, USA. Electronic address: kalpana.merchant@northwestern.edu.
Parkinsonism Relat Disord ; 108: 105325, 2023 03.
Article in En | MEDLINE | ID: mdl-36809869
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Limits: Humans Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Limits: Humans Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: United kingdom